Bank of New York Mellon Corp Sells 63,456 Shares of Owens & Minor, Inc. (NYSE:OMI)

Bank of New York Mellon Corp lessened its position in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 10.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 559,465 shares of the company's stock after selling 63,456 shares during the period. Bank of New York Mellon Corp owned about 0.72% of Owens & Minor worth $5,052,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of OMI. Coliseum Capital Management LLC grew its stake in Owens & Minor by 31.3% in the 4th quarter. Coliseum Capital Management LLC now owns 4,785,964 shares of the company's stock valued at $62,553,000 after buying an additional 1,141,483 shares during the last quarter. Freestone Grove Partners LP acquired a new position in Owens & Minor in the 4th quarter valued at about $5,125,000. Deutsche Bank AG boosted its holdings in Owens & Minor by 77.0% in the 4th quarter. Deutsche Bank AG now owns 495,111 shares of the company's stock valued at $6,471,000 after purchasing an additional 215,455 shares during the period. Norges Bank bought a new stake in Owens & Minor in the 4th quarter valued at about $2,465,000. Finally, Kennedy Capital Management LLC boosted its holdings in Owens & Minor by 15.5% in the 4th quarter. Kennedy Capital Management LLC now owns 1,216,859 shares of the company's stock valued at $15,904,000 after purchasing an additional 163,184 shares during the period. Institutional investors and hedge funds own 98.04% of the company's stock.

Owens & Minor Stock Performance

Shares of Owens & Minor stock remained flat at $7.88 on Monday. 706,445 shares of the stock were exchanged, compared to its average volume of 925,448. The firm's 50 day simple moving average is $7.78 and its 200 day simple moving average is $8.63. Owens & Minor, Inc. has a 12 month low of $6.07 and a 12 month high of $16.85. The company has a debt-to-equity ratio of 3.32, a quick ratio of 0.41 and a current ratio of 1.13. The stock has a market cap of $608.77 million, a price-to-earnings ratio of -1.66, a PEG ratio of 0.35 and a beta of 1.40.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its quarterly earnings results on Saturday, May 10th. The company reported $0.23 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $0.03. Owens & Minor had a negative net margin of 3.41% and a positive return on equity of 17.09%. During the same quarter in the prior year, the firm posted $0.19 earnings per share. The business's revenue was up .7% on a year-over-year basis. On average, equities research analysts expect that Owens & Minor, Inc. will post 1.51 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

OMI has been the subject of a number of recent research reports. Citigroup cut their price objective on shares of Owens & Minor from $13.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, April 17th. Robert W. Baird boosted their price objective on shares of Owens & Minor from $9.00 to $10.00 and gave the company a "neutral" rating in a report on Friday, June 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $11.60.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.